Characterization of CD33 as a new member of the sialoadhesin family of cellular interaction molecules.

CD33 is a member of the Ig superfamily that is restricted to cells of the myelomonocytic lineage but whose functions and binding properties are unknown. It shares sequence similarity with sialoadhesin, CD22, and the myelin-associated glycoprotein, which constitute the Sialoadhesin family of sialic acid-dependent cell adhesion molecules. In the present study, we show that CD33 is a fourth member of this family. As a model for sialic acid-dependent binding, human erythrocytes were derivatized with N-acetylneuraminic acid (NeuAc) in different linkages. A recombinant soluble form of CD33, Fc-CD33, bound red blood cells with a specificity similar to that of sialoadhesin, preferring NeuAc alpha 2,3Gal in N- and O-glycans over NeuAc alpha 2,6Gal in N-glycans. Fc-CD33 also bound selectively to the myeloid cell lines HL-60 and U937. However, CD33 was unable to mediate cell binding after transient expression in COS cells, despite high levels of surface expression. Pretreatment of the CD33-transfected cells with sialidase rendered them capable of mediating sialic acid-dependent binding. These results show that CD33 can function as a sialic acid-dependent cell adhesion molecule and that binding can be modulated by endogenous sialoglycoconjugates when CD33 is expressed in a plasma membrane.

[1]  K. Sakimura,et al.  cDNA cloning of mouse myelin-associated glycoprotein: a novel alternative splicing pattern. , 1989, Biochemical and biophysical research communications.

[2]  S. Gordon,et al.  Sialoadhesin binds preferentially to cells of the granulocytic lineage. , 1995, The Journal of clinical investigation.

[3]  J. Paulson,et al.  Resialylated erythrocytes for assessment of the specificity of sialyloligosaccharide binding proteins. , 1987, Methods in enzymology.

[4]  S. Kelm,et al.  Identification of N-acetylneuraminyl alpha 2-->3 poly-N-acetyllactosamine glycans as the receptors of sialic acid-binding Streptococcus suis strains. , 1992, The Journal of biological chemistry.

[5]  I. Stamenkovic,et al.  Sialylation of the B lymphocyte molecule CD22 by alpha 2,6-sialyltransferase is implicated in the regulation of CD22-mediated adhesion. , 1994, The Journal of biological chemistry.

[6]  B. Seed,et al.  Isolation of a cDNA encoding CD33, a differentiation antigen of myeloid progenitor cells. , 1988, Journal of immunology.

[7]  I. Bernstein,et al.  Treatment of acute myeloid leukemia cells in vitro with a monoclonal antibody recognizing a myeloid differentiation antigen allows normal progenitor cells to be expressed. , 1987, The Journal of clinical investigation.

[8]  G. L. Wilson,et al.  The same epitope on CD22 of B lymphocytes mediates the adhesion of erythrocytes, T and B lymphocytes, neutrophils, and monocytes. , 1993, Journal of immunology.

[9]  A. F. Williams,et al.  The immunoglobulin superfamily--domains for cell surface recognition. , 1988, Annual review of immunology.

[10]  D. Catovsky,et al.  Characterization of myeloid leukemias with monoclonal antibodies 3C5 and MY9 , 1985, Hematological oncology.

[11]  I. Stamenkovic,et al.  The B-cell antigen CD22 mediates monocyte and erythrocyte adhesion , 1990, Nature.

[12]  P. Kirkham,et al.  Identification and characterization of the murine homologue of CD22, a B lymphocyte-restricted adhesion molecule. , 1992, Journal of immunology.

[13]  B. Furie,et al.  Expression cloning of a functional glycoprotein ligand for P-selectin , 1993, Cell.

[14]  R. Ashmun,et al.  Molecular cloning, expression, and chromosomal localization of a human gene encoding the CD33 myeloid differentiation antigen. , 1988, Blood.

[15]  G. Blix,et al.  Sialic Acids , 1955, Nature.

[16]  I. Bernstein,et al.  THE USE OF RADIOLABELED ANTI‐CD33 ANTIBODY TO AUGMENT MARROW IRRADIATION PRIOR TO MARROW TRANSPLANTATION FOR ACUTE MYELOGENOUS LEUKEMIA , 1992, Transplantation.

[17]  C. Fox,et al.  cDNA cloning of the B cell membrane protein CD22: a mediator of B-B cell interactions , 1991, The Journal of experimental medicine.

[18]  B. Young,et al.  Molecular cloning of two isoforms of the murine homolog of the myeloid CD33 antigen , 1994 .

[19]  K. Sasaki,et al.  Expression cloning of a novel alpha 1,3-fucosyltransferase that is involved in biosynthesis of the sialyl Lewis x carbohydrate determinants in leukocytes. , 1994, The Journal of biological chemistry.

[20]  J. Roder,et al.  The myelin-associated glycoprotein gene: mapping to human chromosome 19 and mouse chromosome 7 and expression in quivering mice. , 1987, Genomics.

[21]  D. Eijnden,et al.  Enzymes associated with glycosylation , 1993 .

[22]  R. Eddy,et al.  Chromosome mapping and organization of the human beta-galactoside alpha 2,6-sialyltransferase gene. Differential and cell-type specific usage of upstream exon sequences in B-lymphoblastoid cells. , 1993, The Journal of biological chemistry.

[23]  R. Cummings,et al.  Characterization of a specific ligand for P-selectin on myeloid cells. A minor glycoprotein with sialylated O-linked oligosaccharides. , 1993, The Journal of biological chemistry.

[24]  D. Sgroi,et al.  The B lymphocyte adhesion molecule CD22 interacts with leukocyte common antigen CD45RO on T cells and α2–6 sialyltransferase, CD75, on B cells , 1991, Cell.

[25]  S. Larson,et al.  Murine and humanized constructs of monoclonal antibody m195 (anti‐cd33) for the therapy of acute myelogenous leukemia , 1994, Cancer.

[26]  J. Rossier,et al.  Molecular characterization of the schwann cell myelin protein, SMP: Structural similarities within the immunoglobulin superfamily , 1992, Neuron.

[27]  N. Taniguchi,et al.  Total metabolic flow of glycosphingolipid biosynthesis is regulated by UDP-GlcNAc:lactosylceramide beta 1-->3N-acetylglucosaminyltransferase and CMP-NeuAc:lactosylceramide alpha 2-->3 sialyltransferase in human hematopoietic cell line HL-60 during differentiation. , 1992, The Journal of biological chemistry.

[28]  D. Shotton,et al.  Purification and properties of sialoadhesin, a sialic acid‐binding receptor of murine tissue macrophages. , 1991, The EMBO journal.

[29]  R. Cummings,et al.  Identification of a specific glycoprotein ligand for P-selectin (CD62) on myeloid cells , 1992, The Journal of cell biology.

[30]  A. F. Williams,et al.  Structural diversity in domains of the immunoglobulin superfamily. , 1989, Cold Spring Harbor symposia on quantitative biology.

[31]  S. Watson,et al.  An endothelial ligand for L-Selectin is a novel mucin-like molecule , 1992, Cell.